Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Best CBD Oil Brands in the USA


ValidCBDOil provides independent reviews of top CBD products. We compiled the list of the leading CBD brands that offer high-quality, lab-tested CBD products at affordable prices

ValidCBDOil was launched to let customers learn everything about CBD and select from the best CBD oil products manufactured by top CBD oil brands. ValidCBDOil aims to provide customers with accurate and relevant information concerning CBD application specifics and the peculiarities of each product type currently available on the market. Likewise, ValidCBDOil updates reviews of CBD oil brands regularly.

Hemp-derived products have become increasingly popular recently. Despite the lockdown, the demand for CBD oil products has only grown steadily. In 2020, the total of CBD sales already surpassed 1.1. billion dollars, showing a 41% increase compared to 2019 (813.2 million). CBD is claimed to show better results compared to placebo in treating such ailments as pain, anxiety, depression, insomnia, nausea, and epilepsy.

Several studies showed the promising anti-inflammatory and pain-relieving properties of CBD. It was revealed to inhibit inflammatory processes and act as a remedy for such ailments as arthritis and neurological pain. CBD’s neuroregulatory properties have shown efficiency against rare and severe forms of epilepsy when combined with anti-seizure medication. It was also revealed that CBD promotes the reduction of seizures in patients who had severe epilepsy.

This fact is the answer to the growing popularity of CBD oil. For example, in 2019 alone, it was used for relieving pain in 64% of consumers, while 42% of respondents used CBD oil to improve sleep.

CBD oil is reported to have side effects in 26% of cases, which does not prevent users from purchasing CBD products. According to the CR nationally representative survey of 2019, 22% of consumers preferred to get CBD oil online. Therefore, a large variety of CBD brands emerged in the market. While the question of where to buy CBD oil is no longer a problematic one, finding the best brands of CBD oil can, however, be challenging for regular consumers. It requires searching for CBD oil reviews, comparing the pricing policies of brands, and determining whether a particular CBD manufacturer is reliable. At the same time, it is essential for safe CBD consumption.

ValidCBDOil presented a list of the top CBD brands to let consumers choose safe, lab-tested, and high-quality products:

American Shaman (Kansas City, MO)

Green Gorilla (Malibu, CA)

Charlotte’s Web (Boulder, CO)

Foria (California City, CA)

Green Roads (Deerfield Beach, FL)

Verified CBD (Miami, FL)

Hemplucid (Provo, UT)

Hempworx (Las Vegas, NV)

CBD Living (Corona, CA)

Joy Organics (Fort Collins, CO)

Share article on social media or email:

Anderson Longevity Clinic Launches Franchise Opportunity


Dr Brian D. Anderson, Anderson Longevity Clinic

Dr Brian D. Anderson, President & Founder

“We are looking for motivated, teachable individuals, who are looking to be financially successful while maintaining high ethics and serve their surrounding community. This is an opportunity to tap into an existing high-margin market with the ability to scale and provide outstanding patient care,”

Anderson Longevity Clinic, a personalized luxury medical clinic, has launched a franchise opportunity on its 7th Anniversary.

Anderson Longevity Clinic was founded by Dr Brian D. Anderson, who realized the strong need for anti-aging medical care for those who wanted to go beyond what traditional medical care had to offer. “When I was working in traditional medical clinics, I witnessed how broken the traditional medical model is,” recalled Anderson. “Many waited for over an hour to see their provider for five minutes. Both the patient and Doctor were unhappy with the old process”. Dr Anderson said that he wanted to develop protocols and procedures that were based on cutting edge research instead of waiting 10 years to use it. In 2013 Anderson launched the first medical clinic in a functional fitness type gym. After seeing how popular this initial concept was and the local buzz surrounding it, he decided to expand that same year.

The franchise launch during COVID pandemic comes at a time when personalized medicine is flourishing. Many do not want to visit a traditional healthcare setting with 20 other patients in a waiting room, let alone wait an hour there. Over the past few years there has been a natural increase in the number of patients who value both their time and the level of medical service that they receive. Many also appreciate a holistic viewpoint that focuses on research-based results.

The cutting-edge concept has little competition in the franchise space and has a successful 7-year track record. Dr. Anderson explained the goals of the franchise, “We are looking for motivated, teachable individuals, who are looking to be financially successful while maintaining high ethics and serve their surrounding community. This is an opportunity to tap into an existing high-margin market with the ability to scale and provide outstanding patient care,” said Anderson.

About Anderson Longevity Clinic: Since 2013, Anderson Longevity Clinic has provided cutting edge medical care to those who wish to go beyond what traditional medical care has to offer. Hormone Treatment, Injection Based Injury Care, Facial Cosmetic Treatment, & Unique Lab Testing are all offered at the Clinic. For more information visit: https://AndersonClinicFranchise.com.

Share article on social media or email:

Team PHenonmenal Hope Announces 2020 Research Award Winner to Advance Treatment of Pulmonary Hypertension


News Image

We were extremely impressed with the quality of submissions for this funding opportunity, but Ms. Menezes’s stood out to the reviewers as truly aligning with the mission of Team PHenomenal Hope, by contributing to the field of pulmonary hypertension and also advocating for patients.

Team PHenomenal Hope, a nonprofit dedicated to improving the lives of those with pulmonary hypertension, is proud to announce the winner of the second annual award of $50,000 from the PHenomenal Impact Fund for Global PH Research.

After careful consideration, the research committee selected the proposal by Paula Menezes, titled “Living with Pulmonary Hypertension in Latin America: A Patient’s Perspective.” The committee realized the importance of this research as it has been shown that patient quality of life is associated with increased survival. Ms. Menezes’s research aims to reveal and analyze the needs and challenges that 22,600 patients and caregivers face living with pulmonary hypertension (PH) in Brazil, Colombia, Mexico, Paraguay, and Peru. This research study will interview healthcare providers and patients, as well as parents of pediatric patients, to better understand patients’ quality of life and outcomes.

The unprecedented end result will enrich how public and private policies for PH patients can be developed to better impact people’s lives in the region and allow the development of a global project with Team PHenomenal Hope to influence Latin American stakeholders in order to push them to provide the needed assistance for the PH community.

Dr. Hap Farber, Chair of the Research Committee, shared, “We were extremely impressed with the quality of submissions for this funding opportunity, but Ms. Menezes’s stood out to the reviewers as truly aligning with the mission of Team PHenomenal Hope, by contributing to the field of pulmonary hypertension and also advocating for patients.”

The award was announced at the first annual Team PHenomenal Hope Research Town Hall, a virtual Zoom meeting where prominent researchers in the field explained the latest in research findings in pulmonary hypertension, and entertained questions and answers from patients, caregivers, and other members of the pulmonary hypertension community. The event was attended by more than 70 people from 10 countries.

The PHenomenal Impact Fund opened in January of this year to reward studies of clinical research/need in the field of pulmonary hypertension. As such, this program aims to provide an opportunity for individuals to improve the quality of medical care and improve the lives of patients with pulmonary hypertension.

The research fund was initially seeded with money donated from patient and activist, Julia Feitner, who lives with pulmonary hypertension and organized an annual PHenomenal Hope 5K in Pittsburgh, Pennsylvania. The event continues today under the leadership of Kayla Frattini, who raised more than $35,000 for PH research with the virtual PHenomenal Hope 5K this year. Team PHenomenal Hope is also thankful for the fundraising efforts of volunteer Team PH athletes and other event organizers around the country.

PH is a rare disease that causes high blood pressure in the arteries of the lungs, which puts unnecessary stress on both the heart and then lungs. Currently, there is no cure, and, eventually, it can be fatal. One of the most aggressive symptoms of the disease is shortness of breath, which prevents patients from being able to do ordinary things, such as climbing the stairs, without becoming exhausted.

Team PHenomenal Hope is a nonprofit organization based in Beloit, Wisconsin. As a charity, Team PH seeks to raise awareness of PH, to fund medical research, and to implement programming that focuses on helping patients, including removing patients from isolation, building community, and providing hope.

For more information about Team PH’s race toward a cure, or to donate to the cause, visit http://www.teamph.org.

Share article on social media or email:

McDermott Will & Emery Partners With Homethrive to Offer Employees Family Elder Care Benefit


News Image

Today, family elder care coordinator Homethrive announced its partnership with international law firm McDermott Will & Emery to offer their employees a fully-covered family caregiver services benefit as part of the Firm’s broader benefits package. McDermott will offer Homethrive’s services to all employees in their US offices available immediately. Through Homethrive, the Firm’s employees will have access to Care Guides assigned to each family who provides coaching and concierge services for aging loved ones living at home, ultimately reducing employee stress. Offering Homethrive to its employees builds upon the Firm’s commitment to the American Bar Association’s (ABA) Well-Being Pledge, which prioritizes increased mental health and overall well-being support among legal employers.

The hidden costs of the care economy affect both employers and employees. According to a Harvard Business School survey, three out of four employees reported having some type of caregiving responsibility and more than 80 percent of employees reported caregiving has affected their productivity at work. The impact of caregiving responsibilities has the potential to cause employees to not fully achieve their potential in the workplace, lose productivity, or possibly end a successful career early.

“As part of our ABA pledge, we are committed to providing wellness programs with a focus on mental health awareness and support to our lawyers, professional and administrative staff alike, especially during these uncertain times. We are happy to partner with Homethrive as an additional resource to an already robust benefits package that aids caregivers and their families,” said Alyona S. Richey, McDermott’s Benefits Director.

“We are delighted to be partnering with McDermott Will & Emery to help ease the burden of family caregiving that might be affecting their employees,” says Dave Jacobs, Co-founder & Co-CEO at Homethrive. “McDermott Will & Emery recognizes that especially now during the pandemic is a great time to invest in a family caregiving benefit as their employees may be worried about aging loved ones more than ever. The isolation and loneliness experienced by older adults also has the potential to significantly affect their caregivers working at McDermott Will & Emery and we commend the Firm for providing additional support to their employees during these challenging times.”

Homethrive works by matching each employee with a Care Guide that serves as a coach. Care Guides work with employees to learn about the loved one, identify opportunities, recommend, and arrange services to help the employee shoulder the burden of caregiving.

About McDermott Will & Emery:

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,100 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.

About Homethrive:

Homethrive is a family elder care coordinator that reduces the work, worry, and stress on a family caregiver. The company takes the uncertainty and stress out of caring for an aging loved one by offering expert coaching and concierge services by assigning a Care Guide to each family. The company’s Care Guides also recommend and arrange any necessary third-party supportive services to provide meals, transportation, home care, medication delivery, or other services. To learn more, visit http://www.homethrive.com.

Share article on social media or email:

Lakeland Medical Center has the best value outcomes for Renal Failure in Saint Joseph, MI


best value outcomes for Renal Failure in Saint Joseph, MI

“Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalization, rehospitalization, home health, nursing home, and ED costs.”

Dexur’s analysis of medicare claims of hospitals within a 50-mile radius of Saint Joseph, Michigan, showed that Lakeland Medical Center had the best value outcomes over a 90 day episode for Renal Failure, followed by Ascension Borgess Hospital, and Bronson Methodist Hospital. Dexur’s value analysis tracks a patient’s episode of care from the date of admission for 90 days and includes the index hospitalizations, rehospitalization, home health, nursing home, and ED costs. Total cost of care data helps patients make appropriate choices and helps local ACOs, such as Federation ACO, LLC, make appropriate referral choices. The analysis was risk-adjusted, for alive and non-hospice patients and was done at the DRG level, specifically DRG 683: Renal Failure With Complication Or Comorbidity (CC), to adjust for complications and comorbidities.

Lakeland Medical Center’s total cost of care over a 90 day episode was $14,160 (for the period between July 2016 and June 2019). The index hospitalization cost was $5,791 and the average rehospitalization cost per hospitalization was $5,171. The cost per rehospitalization was at an average of $17,747. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,060.

Ascension Borgess Hospital’s total cost of care over a 90 day episode was $15,794 (for the period between July 2016 and June 2019). The index hospitalization cost was $6,330 and the average rehospitalization cost per hospitalization was $5,194. The cost per rehospitalization was at an average of $17,045. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,113.

Bronson Methodist Hospital’s total cost of care over a 90 day episode was $16,602 (for the period between July 2016 and June 2019). The index hospitalization cost was $7,530 and the average rehospitalization cost per hospitalization was $5,126 The cost per rehospitalization was at an average of $19,789. Meanwhile, the average ED costs per hospitalization (when ED is involved) was $1,106.

Share article on social media or email:

Responsum Health Supports Fibroids Community with New Empowerment Platform


News Image

Responsum for Fibroids is a groundbreaking effort that aligns with our mission and builds on our efforts to raise awareness about the prevalence and consequences of fibroids for American women.

Today, Responsum Health (Responsum) announced the launch of an online empowerment, knowledge, and support platform for women with uterine fibroids (UF)—a condition that affects 70% to 80% of all women by the age of 50. Provided in partnership with The White Dress Project and CARE About Fibroids—two of the nation’s leading fibroids support organizations—and with support and collaboration from AbbVie, a global research-driven biopharmaceutical company, Responsum for Fibroids is available for free via web browser or mobile app.

Thoughtfully designed to best serve fibroids patients and their families, Responsum for Fibroids provides users with a toolkit of useful, community-oriented features. The platform replaces undependable web aggregators and social sites with a personalized Newsfeed that delivers easy-to-read summaries of important fibroids news and information from across the internet every day. Moreover, all Responsum for Fibroids content is written by professional health writers and vetted by a team of researchers under the guidance of patients and medical experts at The White Dress Project and CARE About Fibroids.

Other features include the Community Chat, a moderated social wall where women can share experiences and advice; automatic translation into seven languages; and the Patient One-Sheet, which allows patients to easily collect, maintain, and print their key medical information. Members will also have access to Responsum’s robust collection of trusted patient resources, including financial assistance and support groups.

“Uterine fibroids is one of the most prevalent—and little discussed—chronic health challenges that women face, especially women of color,” said Responsum Health Founder and CEO Andrew Rosenberg. “We are excited to be partnering with The White Dress Project and CARE About Fibroids, with support from AbbVie, to bring women a state-of-the-art app to help them better understand their treatment options; develop strategies to improve their health and quality of life; and find community among others who are facing the same challenge.”

“CARE About Fibroids is dedicated to supporting innovation and educational efforts that will help ease the burden on women living with symptomatic uterine fibroids,” said Nancy Lee, M.D., a member of CARE About Fibroids’ Science Advisory Committee. “Responsum for Fibroids is a groundbreaking effort that aligns with our mission and builds on our efforts to raise awareness about the prevalence and consequences of fibroids for American women.”

“For years, our organization has closely followed the stories of many women with fibroids who have been fighting in silence, overwhelmed by the amount of misinformation and almost non-existing support,” said Tanika Gray Valbrun, founder of The White Dress Project. “Our partnership with Responsum Health will allow us to make substantial progress by providing patients and caregivers with accurate information and credible resources to help them become more empowered patients and drive better health outcomes.”

About Responsum Health

Responsum Health’s mission is to build and support online knowledge communities for chronic disease patients. The company offers a free, revolutionary patient engagement platform that monitors, searches, and curates the internet to generate a personalized Newsfeed of article summaries, which are vetted by Responsum’s patient group partners. Each comprehensive platform enables patients to comment on and rate articles, as well as share them with their professional care team and loved ones. Responsum also helps patients to better organize their health information, find local patient support groups and services, and support one another through a moderated, disease-specific social wall.

About The White Dress Project

The White Dress Project is one of the leading patient advocate organizations for women with fibroids. Their mission is to galvanize support globally, lead awareness efforts, and raise funding for uterine fibroids research and education. The White Dress Project aims to empower women to share their stories to collectively highlight the importance of this issue.

About CARE About Fibroids

CARE About Fibroids is taking the lead in mobilizing women’s health advocacy and policy-focused organizations to build greater awareness of uterine fibroids, as well as a sense of urgency around the need for improved diagnosis, expanded and better treatment options, and enhanced patient access to appropriate care.

Share article on social media or email:

Bestselling Author Releases Free Deep Dive Educational Webinar and Book on Levothyroxine, the Most Prescribed Medication for Hypothyroidism


The free Levothyroxine Deep Dive program features three video webinars, a detailed online guide, and a book

The free Levothyroxine Deep Dive program features three video webinars, a detailed online guide, and a book

“Most doctors whip out a prescription pad, with little time to review the pros and cons of a patient’s levothyroxine options. The Deep Dive fast-forwards patients quickly up the learning curve, allowing them to advocate for the treatment that will work best for them, and save money.”

Mary Shomon — a New York Times bestselling author of 15 books, nationally-known thyroid patient advocate, and hormonal health coach — is announcing the release and publication of the Levothyroxine Deep Dive, a comprehensive, free educational program about levothyroxine for people with hypothyroidism. The Levothyroxine Deep Dive program includes a 3-part video webinar series, an online web-based guide, fact sheets on each brand-name levothyroxine drug, and a book: “The Complete Guide to Levothyroxine.” .

Hypothyroidism — a condition caused by an underactive thyroid gland — affects an estimated 16 million Americans. It’s estimated that an additional 20 to 30 million more Americans have an undiagnosed thyroid condition, usually hypothyroidism. The majority of people with hypothyroidism are treated with the drug levothyroxine, a synthetic form of thyroxine, one of two key hormones produced by the thyroid gland. Levothyroxine consistently ranks as one of the top five most prescribed category of drugs across the globe.

“Research shows that up to one-third of the millions of Americans taking levothyroxine are not receiving adequate treatment and still have abnormal thyroid test levels,” said Mary Shomon. “And more than half of those patients report continuing symptoms of hypothyroidism, despite treatment. I created the Levothyroxine Deep Dive to empower patients with all the information they need to make treatment choices that will help them truly feel and live well.”

To support patients receiving inadequate treatment and struggling with symptoms, Mary Shomon is making the full ad-free Levothyroxine Deep Dive program available at no-cost, with no registration required, as an educational resource for the millions of hypothyroid patients taking levothyroxine. The Levothyroxine Deep Dive is located at https://www.mary-shomon.com/dive.

THE “LEVOTHYROXINE DEEP DIVE” HELPS THYROID PATIENTS…

1. Know all their levothyroxine treatment options, covering different forms — tablets, capsules, or oral solution — and brands, including Levoxyl®, Synthroid®, Tirosint®, Tirosint®-SOL, Unithroid®, as well as the generic levothyroxine category.

2. Identify the different dyes, fillers and binders (known as excipients) in each levothyroxine brand and the generic versions available in the U.S.

3. Identify the subjective pros and cons of different brands of levothyroxine, as well as the generic versions, considering their own health histories, past experience, treatment responses, lifestyle, and ability to afford medication.

4. Be aware — and take advantage — of the many ways to save money on their preferred brand name or generic levothyroxine medication.

5. Recognize how their particular levothyroxine treatment may present challenges and obstacles to safe and optimal resolution of their hypothyroidism.

6. Troubleshoot safe and effective solutions to help resolve specific levothyroxine challenges.

PART 1: LEVOTHYROXINE OPTIONS

Part 1’s video webinar and online guide is located at https://www.mary-shomon.com/levothyroxine-options and reviews all “Levothyroxine Options” available to patients, including the three different forms of levothyroxine and their manufacturers. The dyes, excipients, and potency variations in different brand name and generic levothyroxine drugs are identified and explained, along with their possible effects on hypothyroidism treatment.

This first part of the Levothyroxine Deep Dive also explores the challenges patients face when taking generic levothyroxine, and when it’s appropriate to consider switching from generic to brand name levothyroxine, switch between brands, or switch from tablets to the capsule or oral solution forms of levothyroxine.

PART 2: LEVOTHYROXINE COSTS AND SAVINGS

Part 2 of the Levothyroxine Deep Dive is located at https://www.mary-shomon.com/levothyroxine-costs and focuses on “Levothyroxine Costs and Savings,” with specific guidelines on how patients can afford — and save on the cost of — their levothyroxine medication.

The Part 2 video webinar and guide explain how levothyroxine drugs are distributed and priced, and details the specific insurance copayments and tiers for generic and brand name levothyroxine drugs. Step-by-step guidance on how to take advantage of manufacturer copay cards, discount coupons, and patient assistance programs for brand name levothyroxine is provided.

Part 2 also details the best discount programs offered by pharmacies, grocery stores and other retailers such as Walmart and CVS, and as well as outside programs like GoodRx and SingleCare. Especially pertinent in the time of COVID-19 is the discussion of saving on levothyroxine by using mail-order pharmacies.

Finally, Part 2 of the Levothyroxine Deep Dive explains the concept of “clawbacks,” and how and why many patients are overpaying for levothyroxine, and how paying retail cash prices may save them money, versus their insurance copay.

PART 3: RESOLVING LEVOTHYROXINE CHALLENGES

Part 3 of the program is located at at https://www.mary-shomon.com/levothyroxine-challenges and the video webinar and guide cover “Resolving Levothyroxine Challenges,” identifying 18 scenarios that frequently sabotage a thyroid patient’s ability to get effective levothyroxine treatment for their hypothyroidism.

In particular, this part of the Levothyroxine Deep Dive identifies common issues that can negatively affect absorption of levothyroxine, including:


  • Lactose intolerance
  • Seasonal allergies/hay fever
  • Gluten sensitivity, intolerance, or celiac disease
  • Iodine sensitivity
  • Gastrointestinal or digestive illnesses
  • A diet high in fiber, or soy foods and supplements
  • The timing of breakfast, coffee, or milk versus levothyroxine
  • Taking other medications and supplements, including proton pump inhibitors, antacids, and calcium or iron supplements

Part 3 also discusses some key challenges patients face in filling prescriptions, including:

  • High insurance copays for — and difficulty affording — Synthroid®, Tirosint® or Tirosint®-SOL
  • Pharmacies that substitute lower-cost brand name or generic levothyroxine tablets for patients who specifically need higher-priced brands
  • Pharmacies that claim not to have Tirosint® or Tirosint®-SOL in stock, or say it’s “unavailable”

“Every hypothyroid patient taking levothyroxine can benefit from the Deep Dive,” says Mary Shomon. “Most doctors whip out a prescription pad, with little time to review the pros and cons of a patient’s levothyroxine options. The Deep Dive fast-forwards patients quickly up the learning curve, preparing them to advocate for the treatment that will work best for them, and save up to hundreds of dollars a year. And, given the pandemic, more patients than ever before are facing a struggle to afford a daily medication they desperately need.”

LEVOTHYROXINE FACT SHEETS

Detailed levothyroxine fact sheets summarize the key information — including manufacturer contacts, websites, excipients, dyes, dosage sizes, pricing, and discount programs — for brand name and generic levothyroxine:

BOOK: “THE COMPLETE GUIDE TO LEVOTHYROXINE”

“The Complete Guide to Levothyroxine” — weighing in at almost 100 pages — covers all the information featured in the three webinars and online guides. The PDF format of this downloadable ebook also includes clickable links to all the featured sites and resources. The book can be downloaded at https://www.mary-shomon.com/free-levothyroxine-book.

The full Levothyroxine Deep Dive program, including video webinars, online guides, fact sheets, and book, is located at https://www.mary-shomon.com/dive.

ABOUT MARY SHOMON

Mary Shomon is a patient advocate, health coach, consultant, and New York Times bestselling author of 15 books on thyroid and autoimmune disease, weight loss and hormonal health, including “The Thyroid Diet,” and “Living Well with Hypothyroidism.” For more than two decades, Mary has been a trailblazer in advocating for more effective, patient-centered hormonal healthcare. In addition to her advocacy and coaching, Mary serves as a corporate consultant, providing strategic guidance on thyroid-related marketing, outreach, and patient-directed communications.

Mary writes for and hosts broadcast interviews for popular consumer health website HealthCentral.com where she also serves on their Health Advocates Advisory Board. Mary is the resident Thyroid Expert for, and contributor and advisor for patient-directed site ThyroidRefresh.com. Mary also regularly contributes to pioneering thyroid care telemed provider PalomaHealth.com.

Mary is the founder of the popular Thyroid Tuneup 10-step educational program for optimizing hypothyroidism treatment, and the Hormonal Havoc program, providing a multidisciplinary, hormonally-based approach to weight loss for women over 40.

On social media, Mary empowers and informs a community of more than a quarter million patients who have thyroid and hormonal health challenges:

Twitter: https://www.Twitter.com/ThyroidMary

Instagram: https://www.Instagram.com/ThyroidMary

Facebook: https://www.Facebook.com/ThyroidSupport

Facebook: https://www.Facebook.com/ThyroidDiet



Roundtrip hauls in a $4M strategic capital raise


Roundtrip

The Roundtrip platform in desktop and mobile view.

“In the midst of an ongoing pandemic, this funding is continued validation of our focus” – Mark Switaj, CEO, Roundtrip

Roundtrip, the leading digital transportation marketplace for better health outcomes, announced the completion of a $4 million capital raise earlier this morning bringing its total amount of financing to $10.5 million. Motley Fool Ventures and ZOLL® Medical Corporation each participated, with Motley Fool Ventures as lead. UH Ventures, the innovation and commercialization division of University Hospitals health system in Cleveland, and Grays Ferry Capital also joined the ranks of the company’s existing list of investors, including Johns Hopkins University and Ben Franklin Technology Partners.

The capital raise will allow Roundtrip to geographically scale and specialize its sales, implementation and account management model, expand its health plan portfolio and technology integration capabilities, and grow the Roundtrip Community — a customized online marketplace that streamlines medical transportation providers to rides requested by health systems and health plans, meeting an entire population’s transportation needs. Ultimately, the strategic raise will enable Roundtrip to expand its “category of one” position as the most experienced and comprehensive solution for non-emergency medical transportation in the United States.

Founded in 2016, Roundtrip has built impactful partnerships in over 40 states, and is currently used across the healthcare landscape. Since its Series A, the company has expanded its client base with health systems like Lifespan Health and the National Institutes of Health, while also adding to its portfolio of Medicare Advantage and other plans, with Community Health Plan of Washington and Contra Costa Health Plan.

“In the midst of an ongoing pandemic, this funding is continued validation of our focus,” said Roundtrip CEO and Founder Mark Switaj. “The future is in disease-state transportation solutions, and our outcomes-based view crosses COVID-19, the opioid crisis, cardiology, radiology, and cancer care, plus behavioral health and more. With missed appointments costing our nation’s healthcare system $150 billion every year, it’s important to understand the riders and how transportation needs differ. Our marketplace model is making a real difference for our customers, their preferred transportation options, and their patients. The strategic investments from ZOLL Medical Corporation, a leader in medical devices and related software solutions that help advance patient care, and University Hospitals, one of the largest health systems in Ohio, is further affirmation of our product and the place it has in driving better health.”

“It is really encouraging to see companies like Roundtrip tackle and solve compliance and efficiency challenges in the non-emergent medical transport segment. The impact that Roundtrip has had on reducing patient no-shows while increasing patient satisfaction has positioned them as the clear leader in the industry,” said Alex Moghadam, President of ZOLL Data Systems. “The entire ZOLL team is excited about the continued growth of the company.”

About Roundtrip

Roundtrip is the leading digital transportation marketplace for better health outcomes. We provide a simple, comprehensive patient ride ordering software that makes available a community of ride providers who complete the transport. The company is leading the industry in reducing patient no-shows through improved ride management.

Roundtrip is built for healthcare professionals — care coordinators, social workers, nurses, and other transport requestors —and offers easy-to-use online and mobile platforms that connect patients with non-emergency medical transportation (NEMT). Roundtrip is a comprehensive solution that supports all levels of transport: medical cars, wheelchair vans, stretcher vehicles, ALS/BLS ambulances, all payers, and all trips delivered when and where they are needed.

Roundtrip is doing more than expanding access to care; we are changing how people manage their health in their everyday lives. As we address social determinants of health and aging in place, Roundtrip is driven to deliver engaged and empowered transportation experiences for riders.

To learn more about Roundtrip, please visit http://www.roundtriphealth.com

Media inquiries can be channeled to press@roundtriphealth.com

About Motley Fool Ventures

Based in Alexandria, Va., Motley Fool Ventures brings The Motley Fool’s investing principles and member community to venture capital. Launched in 2018, Motley Fool Ventures invests in early-stage companies that leverage technology to create a clear competitive advantage in their industry. Its dedicated team, investor community, and robust network aim to provide value to entrepreneurs beyond just capital.

To learn more about Motley Fool Ventures, please visit http://www.foolventures.com.

Share article on social media or email:

Labyrinthe Labs Discusses Benefits of Beta-Caryophyllene (BCP) in Lefa Product Line


News Image

The entourage of phytocannabinoids in full spectrum hemp oil provides maximum support to the endocannabinoid system which helps regulate systems in your body that have a significant impact on managing pain sensation and inflammation.

Labyrinthe Labs announced an initiative to educate consumers about the unique ingredients used in their product formulations. They recently launched their innovative soothing topical cream, designed for fast-action relief of joint and muscle soreness, Lefa. The cream is formulated with menthol and over 3,000mg of CBD and Beta-Caryophyllene (BCP).

BCP, a cannabinoid, is a common constituent of the essential oils of numerous spice and food plants, including unripe black pepper seed, and a major component in cannabis sativa (hemp). Cannabinoids are naturally occurring in the body, and they support the endocannabinoid system (ECS), which works to balance the various processes in the body to achieve homeostasis impacting inflammation, pain management, sleep, stress, and more.

ECS receptors in the body are naturally accepting to BCP to help regulate and ensure the inflammatory system is working properly. To fully support the ECS, taking CBD alone will not provide the expected benefits that consumers hope for. This is why the formulators of Lefa combined the full spectrum of phytocannabinoids in hemp, including CBD, with the powerful cannabinoid BCP – so Lefa could be better than CBD alone. When topically applied, it binds to a receptor in the body that accepts cannabinoids – CB2. These pain support ingredients in addition to Menthol, Boswellia, Arnica and MSM help with inflammation and soothe sore, stiff muscles and joints. BCP is also known to address neuropathic pain according to study conducted in 2012.

“The ingredient beta-caryophyllene is what makes our Lefa line completely unique,” said Tracy Meyer, Vice President of Operations and Marketing at Labyrinthe Labs. “The entourage of phytocannabinoids in full spectrum hemp oil provides maximum support to the endocannabinoid system which helps regulate systems in your body that have a significant impact on managing pain sensation and inflammation.”

To learn more about the science behind Lefa and its products, visit http://www.lefalabs.com.

About Labyrinthe Labs

Labyrinthe Labs was founded in January 2020 as a complete, multi-layered product development, direct response and brand marketing operation. Its team has spent the last 20 years developing new, innovative and scientifically efficacious products with steady mass consumer appeal spanning from baby boomers all the way through millennials.

Share article on social media or email:

NFP and Helios HR Introduce Findings on Successful Leave Benefits


News Image

“We’re excited to offer the leave benefits report to our clients and continue demonstrating our commitment to supporting informed choices with relevant data and insight,” said Kim Bell, NFP’s senior vice president, head of health and benefits.

NFP, a leading insurance broker and consultant that provides property and casualty (P&C), corporate benefits, retirement, and individual solutions, today announced the publication of a leave benefits report in collaboration with Helios HR, a leading human capital and talent acquisition consulting firm. NFP and Helios partnered to survey more than 190 companies, representing 16 states and 16 industries, to assess the prevalence of certain leave benefits and the perceived value of those benefits for employees.

The leave benefits report is designed to support business decisions related to paid leave benefits for employees through insights on the types of leave being offered, typical amounts of time off, program structures and more. Key findings include the challenges employers overcome to provide certain leave benefits, including paid time off, paid parental leave and holidays, as well as the success employers realize in offering these benefits to employees. The survey also uncovered the added flexibility employers are providing through customized leave and return-to-work programs designed to attract and retain employees.

The report is available to NFP clients that want to access industry and regional data as they evaluate employee leave options. While the survey was conducted nationally, trends for specific regions, industries and employer-size groups in conjunction with the corresponding national trend should be considered.

“We’re excited to offer the leave benefits report to our clients and continue demonstrating our commitment to supporting informed choices with relevant data and insight,” said Kim Bell, NFP’s senior vice president, head of health and benefits. “When organizations have a better understanding of their options and what others are doing, they enhance their ability to implement competitive benefit plans for their employees. We appreciate the collaboration with Helios HR and look forward to the response from our clients.”

“Organizations are under intense pressure to build benefit programs that are meaningful to employees and align with strategic and financial goals,” said Beth Robertson, corporate benefits managing director in NFP’s Mid-Atlantic region. “The leave benefits report is another example of an NFP resource that helps clients manage through this pressure with information, data and perspective. The more insight they have, the better positioned they are to make smart choices, and we’re excited to have the opportunity to be part of that process.”

About NFP

NFP is a leading insurance broker and consultant providing specialized property and casualty, corporate benefits, retirement and individual solutions through its licensed subsidiaries and affiliates. NFP enables client success through the expertise of over 5,600 global employees, investments in innovative technologies, and enduring relationships with highly rated insurers, vendors, and financial institutions. NFP is the 5th largest benefits broker by global revenue, 6th largest US-based privately owned broker, and 8th best place to work in insurance (Business Insurance); 10th largest property and casualty agency (Insurance Journal); and 13th largest global insurance broker (Best’s Review).

Visit NFP.com to discover how NFP empowers clients to meet their goals.

Share article on social media or email: